BlackRock Institutional Trust Company, N.A. - LION BIOTECHNOLOGIES INC ownership

LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 87 filers reported holding LION BIOTECHNOLOGIES INC in Q4 2016. The put-call ratio across all filers is 1.15 and the average weighting 0.5%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of LION BIOTECHNOLOGIES INC
ValueSharesWeighting
Q4 2016$8,814,000
-12.7%
1,268,264
+3.4%
0.00%
-50.0%
Q3 2016$10,098,000
+9.2%
1,227,024
+7.5%
0.00%0.0%
Q2 2016$9,244,000
+61.5%
1,141,201
+1.3%
0.00%
+100.0%
Q1 2016$5,724,000
-34.4%
1,126,786
-0.3%
0.00%0.0%
Q4 2015$8,727,000
+40.8%
1,130,505
+5.1%
0.00%0.0%
Q3 2015$6,198,000
-34.9%
1,075,979
+3.7%
0.00%
-50.0%
Q2 2015$9,519,000
+452.5%
1,038,043
+629.4%
0.00%
Q1 2015$1,723,000142,3070.00%
Other shareholders
LION BIOTECHNOLOGIES INC shareholders Q4 2016
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 3,180,913$18,322,0004.76%
ACUTA CAPITAL PARTNERS, LLC 1,314,959$7,574,0004.38%
Perceptive Advisors 5,910,912$34,046,0001.36%
P.A.W. CAPITAL CORP 200,000$1,152,0001.32%
Ghost Tree Capital, LLC 300,000$1,728,0000.78%
Broadfin Capital, LLC 2,105,519$12,128,0000.68%
Rhenman & Partners Asset Management AB 683,108$3,935,0000.63%
Trellus Management Company, LLC 60,539$349,0000.51%
Cormorant Asset Management, LP 499,815$2,879,0000.46%
QVT Financial LP 1,433,700$8,258,0000.28%
View complete list of LION BIOTECHNOLOGIES INC shareholders